Product Code: GVR-1-68038-001-9
Extracorporeal Membrane Oxygenation Machine Market Growth & Trends:
The global extracorporeal membrane oxygenation machine market size is anticipated to reach to reach USD 445.7 million by 2030, expanding at a CAGR of 5.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of cardiopulmonary and respiratory diseases, increasing adoption of ECMO machines in hospitals, and technological advancements in ECMO machines. The market expansion is also driven by the need for advanced life support technologies like ECMO machines, which are becoming increasingly necessary in treating patients with severe or life-threatening cardiac or pulmonary conditions.
The rising prevalence of cardiovascular and respiratory diseases. Diseases such as coronary heart disease, cerebrovascular disease, rheumatic and congenital heart diseases, respiratory diseases like acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary diseases are leading causes of death worldwide. For instance, according to the World Heart Federation, approximately 18.6 million people die annually from cardiovascular diseases. Additionally , about 190,000 Americans are diagnosed with ARDS annually in the U.S. Such an increasing prevalence of cardiovascular and respiratory diseases has boosted the demand for ECMO machines, driving the market growth.
In addition, the increasing rate of technical improvement is increasing the usage of products. It is easier to transfer critically ill patients now as machine parts like hollow pumps and oxygenators are smaller. Moreover, introducing technologically advanced components, such as improved rotary pumps, dual-lumen cannulas, innovative oxygenators, and new cannulation approaches, is anticipated to ease the use of ECMO machines. For instance, in 2022, Inspira Technologies OXY B.H.N. Ltd. recently introduced the "Liby" System, an advanced life support system used to treat patients with life-threatening heart and lung failure. Similar advancements and the introduction of new products are expected to drive market growth in the coming years.
Extracorporeal Membrane Oxygenation Machine Market Report Highlights:
- In 2023, the oxygenators segment accounted for the largest market share. This can be attributed due to prevalence of diseases like coronary heart disease and chronic obstructive pulmonary disease (COPD) continues to rise, the demand for advanced life support technologies like ECMO machines increases, driving the growth of the oxygenators segment.
- The veno-arterial segment dominated the modality segment of ECMO machine market in 2023. This growth can be attributed due to high usage of veno-arterial ECMO in treating patients with cardiac arrest, where it assists with algorithm life support strategies to restore blood circulation. Additionally, the increasing incidence of chronic obstructive pulmonary disease (COPD) is also a key driver of this market segment.
- The respiratory segment dominated the application segment in 2023 due to the high prevalence of respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and acute respiratory distress syndrome (ARDS), which are leading causes of death worldwide, necessitate advanced life support technologies like ECMO machines.
- The adult patient segment dominated the patient type segment in 2023 due to the prevalent incidence of heart and lung-related issues necessitating life-saving interventions.
- The North American region held the largest share of the market in 2023 due to key industry players, consistent product launches, government backing for quality healthcare, advanced healthcare infrastructure, and favorable reimbursement policies.
- Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. ECMO Machine Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of cardiopulmonary and respiratory diseases
- 3.2.1.2. Increasing adoption of ECMO machines in hospitals
- 3.2.1.3. Technological advancement in ECMO machines
- 3.2.1.4. Growing awareness towards the application of ECMO
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of procedures
- 3.2.2.2. Risk of complications during ECMO procedures
- 3.2.2.3. Presence of conventional technique
- 3.3. ECMO Machine Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. ECMO Machine Market: Component Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. ECMO Machine Market: Component Movement Analysis & Market Share, 2023 & 2030
- 4.3. Pumps
- 4.3.1. Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Oxygenator
- 4.4.1. Oxygenator Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Controllers
- 4.5.1. Controllers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Cannula
- 4.6.1. Cannula Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Accessories
- 4.7.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. ECMO Machine Market: Modality Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. ECMO Machine Market: Modality Movement Analysis & Market Share, 2023 & 2030
- 5.3. Veno-Arterial
- 5.3.1. Veno-Arterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Veno-Venous
- 5.4.1. Veno-Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Arterio-Venous
- 5.5.1. Arterio-Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. ECMO Machine Market: Patient Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. ECMO Machine Market: Patient Type Movement Analysis & Market Share, 2023 & 2030
- 6.3. Neonates
- 6.3.1. Neonates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Pediatric
- 6.4.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Adult
- 6.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. ECMO Machine Market: Application Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. ECMO machine Market: Application Movement Analysis & Market Share, 2023 & 2030
- 7.3. Respiratory
- 7.3.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Respiratory Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
- 7.3.2.1. Neonates
- 7.3.2.2. Pediatric
- 7.3.2.3. Adult
- 7.4. Cardiac
- 7.4.1. Cardiac Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Cardiac Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
- 7.4.2.1. Neonates
- 7.4.2.2. Pediatric
- 7.4.2.3. Adult
- 7.5. ECPR
- 7.5.1. ECPR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. ECPR Market Estimates and Forecast, By Patient Type 2018 - 2030 (USD Million)
- 7.5.2.1. Neonates
- 7.5.2.2. Pediatric
- 7.5.2.3. Adult
Chapter 8. ECMO Machine Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. ECMO Machine Market: Regional Movement Analysis & Market Share, 2023 & 2030
- 8.3. North America
- 8.3.1. North ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. Reimbursement scenario
- 8.3.2.5. U.S. ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Reimbursement scenario
- 8.3.3.5. Canada ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. Europe
- 8.3.5. Europe ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. UK
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Reimbursement scenario
- 8.3.6.5. UK ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Reimbursement scenario
- 8.3.7.5. Germany ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. France
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Reimbursement scenario
- 8.3.8.5. France ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Italy
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Reimbursement scenario
- 8.3.9.5. Italy ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.10. Spain
- 8.3.10.1. Key Country Dynamics
- 8.3.10.2. Competitive Scenario
- 8.3.10.3. Regulatory Framework
- 8.3.10.4. Reimbursement scenario
- 8.3.10.5. Spain ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.11. Denmark
- 8.3.11.1. Key Country Dynamics
- 8.3.11.2. Competitive Scenario
- 8.3.11.3. Regulatory Framework
- 8.3.11.4. Reimbursement scenario
- 8.3.11.5. Denmark ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.12. Sweden
- 8.3.12.1. Key Country Dynamics
- 8.3.12.2. Competitive Scenario
- 8.3.12.3. Regulatory Framework
- 8.3.12.4. Reimbursement scenario
- 8.3.12.5. Sweden ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.13. Norway
- 8.3.13.1. Key Country Dynamics
- 8.3.13.2. Competitive Scenario
- 8.3.13.3. Regulatory Framework
- 8.3.13.4. Reimbursement scenario
- 8.3.13.5. Norway ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Reimbursement scenario
- 8.4.2.5. Japan ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Reimbursement scenario
- 8.4.3.5. China ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Reimbursement scenario
- 8.4.4.5. India ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. South Korea
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Reimbursement scenario
- 8.4.5.5. South Korea ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Australia
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Reimbursement scenario
- 8.4.6.5. Australia ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Reimbursement scenario
- 8.4.7.5. Thailand ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement scenario
- 8.5.2.5. Brazil ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement scenario
- 8.5.3.5. Mexico ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. Argentina
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Reimbursement scenario
- 8.5.4.5. Argentina ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. South Africa ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement scenario
- 8.6.3.5. Saudi Arabia ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement scenario
- 8.6.4.5. UAE ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement scenario
- 8.6.5.5. Kuwait ECMO Machine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. Medtronic Plc
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. Maquet Holding
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Microport Scientific Corporation
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. Terumo Cardiovascular System Corporation
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Medos Medizintechnik
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Nipro Medical Corporation
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. LivaNova PLC
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. CytoSorbents Corporation
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. EUROSETS S.R.L
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives